DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...

The hold followed Intellia’s voluntary pause in response to a grade 4 liver event—a case of Hy’s Law—in the ATTR-CM trial.

CRISPR therapy STX-1150 could replace daily cholesterol pills with a single dose, reducing LDL by 50% for 18+ months using ...

Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...

Researchers developed a chemogenetic system combining caffeine, nanobodies, and CRISPR to control gene editing. The approach ...

If you are trying to work out whether CRISPR Therapeutics is attractively priced or not, starting with the recent share ...

Gene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Why CRISPR Therapeutics Is On Investors’ Radar Today CRISPR Therapeutics (CRSP) has attracted fresh attention after recent trading left the stock around $54.65, with performance mixed over the past ...